MYERS INDUSTRIES INCMYEEarnings & Financial Report
NYSE · Materials · Plastics Products, NEC
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban (Eliquis) for people with atrial fibrillation ; nivolumab (Opdivo), used to treat certain types of cancer ; lenalidomide (Revlimid), used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes ; abatacept (Orencia), used to treat autoimmune diseases such as rheumatoid ...
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| The Vanguard Group | 8.25% | 3.1M | flat | 2024-11-12 |
| BlackRock, Inc. | 8.00% | 3.0M | ▼ -7.90pp | 2024-12-06 |
| Allspring Global Investments Holdings, LLC | 5.78% | 2.1M | — | 2024-01-12 |
| nos. of above persons | 4.18% | 1.6M | — | 2024-12-13 |
| T. Rowe Price Investment Management, Inc. | 2.50% | 920.2K | flat | 2024-02-16 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-23 | DEFEO RONALD M | Director | Disposition | 6.3K | — | — |
| 2026-03-16 | Lorelei Evans | SVP and CHRO | Option exercise | 1.5K | $0.00 | $0 |
| 2026-03-16 | Lorelei Evans | SVP and CHRO | Option exercise | 1.7K | $0.00 | $0 |
| 2026-03-16 | Lorelei Evans | SVP and CHRO | Option exercise | 2.6K | $0.00 | $0 |
| 2026-03-16 | Schapper Aaron M | President and CEO | Option exercise | 26.0K | $0.00 | $0 |
1–5 of 5